ZAFIRLUKAST

SynDRA canonical compound SYN0001085 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYSLTR1
Mechanism of action	Leukotriene receptor antagonist
Indication	asthma
Disease area	pulmonary

All known targets

ICI 204219
ICI 204,219
vanticon
ICI-204219
Accolate
Accoleit
Aeronix
Olmoran
Respix
Zafirst
AstraZeneca brand of zafirlukast
Menarini brand of zafirlukast
Novartis brand of zafirlukast
Zeneca brand of zafirkulast
Accolate (TN)
Accoleit (TN)
Vanticon (TN)
Zafirlukast [USAN:BAN:INN]
Accolate, Accoleit, Vanticon, Zafirlukast
Zafirlukast (JAN/USAN/INN)
Cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate
Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate
Cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate
Cyclopentyl [3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-1H-indol-5-yl]carbamate
Cyclopentyl (1-methyl-3-{[2-(methyloxy)-4-({[(2-methylphenyl)sulfonyl]amino}carbonyl)phenyl]methyl}-1H-indol-5-yl)carbamate
Carbamic acid, (3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl ester
4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide
ICI-204,219
XZ629S5L50
DTXCID303746
CHEBI:10100
zafirlukastum
RefChem:57963
R03DC01
MFCD00864775
NCGC00164547-01